Table 21-3.
Time Trends in GWTG-ACS Quality-of-Care Measures, 2006–2011
Quality-of-Care Measure | 2006 | 2007 | 2008 | 2009 | 2010* | 2011* |
---|---|---|---|---|---|---|
Aspirin within 24 h of admission | 94.7 | 92.8 | 91.2 | 90.9 | 97 | 97.6 |
Aspirin at discharge | 94.4 | 95.8 | 94.9 | 95.5 | 98 | 98.3 |
β-Blockers at discharge | 92.8 | 94.6 | 94.5 | 94.9 | 96 | 96.7 |
Lipid-lowering medication at discharge | 84.5 | 85.6 | 81.6 | 86.8 | 92† | 98.4† |
Lipid therapy at discharge if LDL cholesterol >100 mg/dL | 89.1 | 90.7 | 91.9 | 92.5 | NM | NM |
ARB/ACEI at discharge for patients with LVEF <40% | 87.3 | 91.1 | 91.9 | 91.9 | 86 | 87.8 |
Adult smoking cessation advice/counseling | 94.3 | 97.4 | 98.4 | 98.4 | 98 | 98.4 |
Cardiac rehabilitation referral for AMI patients | 71.1 | 63.6 | 52.0 | 49.1 | 75 | 76.5 |
Values are percentages.
In the ACTION registry (Acute Coronary Treatment and Intervention Outcomes Registry), the unadjusted in-hospital mortality rate for 2011 was 4.6% (95% confidence interval, 4.4%–4.7%); excludes transfer-out patients). The American Heart Association’s (AHA’s) GWTG-CAD has now merged into the ACTION registry.
GWTG-ACS indicates Get With The Guidelines–Acute Coronary Syndrome; LDL, low-density lipoprotein; NM, not measured; ARB/ACEI, angiotensin receptor blocker/ angiotensin-converting enzyme inhibitor; LVEF, left ventricular ejection fraction; and AMI, acute myocardial infarction.
Measures from 2006–2009 are from the AHA’s GWTG-CAD (Coronary Artery Disease) registry. 2010/2011 measures are from the AHA’s ACTION registry (Acute Coronary Treatment and Intervention Outcomes Registry.
Represents statin use.